CA2426684A1 - Inhibiteurs de la prenyl-proteine transferase - Google Patents
Inhibiteurs de la prenyl-proteine transferase Download PDFInfo
- Publication number
- CA2426684A1 CA2426684A1 CA002426684A CA2426684A CA2426684A1 CA 2426684 A1 CA2426684 A1 CA 2426684A1 CA 002426684 A CA002426684 A CA 002426684A CA 2426684 A CA2426684 A CA 2426684A CA 2426684 A1 CA2426684 A1 CA 2426684A1
- Authority
- CA
- Canada
- Prior art keywords
- unsubstituted
- substituted
- alkyl
- heterocycle
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'invention concerne des composés spirocycliques qui inhibent la prényl-protéine transférase et la prénylation de la protéine oncogène Ras. L'invention concerne également des compositions chimiothérapeutiques contenant ces composés, ainsi que des procédés pour inhiber la prényl-protéine transférase et la prénylation de la protéine oncogène Ras.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24323600P | 2000-10-25 | 2000-10-25 | |
US60/243,236 | 2000-10-25 | ||
PCT/US2001/050527 WO2002060868A2 (fr) | 2000-10-25 | 2001-10-19 | Inhibiteurs de la prenyl-proteine transferase |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2426684A1 true CA2426684A1 (fr) | 2002-08-08 |
Family
ID=22917880
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002426684A Abandoned CA2426684A1 (fr) | 2000-10-25 | 2001-10-19 | Inhibiteurs de la prenyl-proteine transferase |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1332134A2 (fr) |
CA (1) | CA2426684A1 (fr) |
WO (1) | WO2002060868A2 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2014216178B2 (en) | 2013-02-15 | 2018-06-28 | KALA BIO, Inc. | Therapeutic compounds and uses thereof |
KR102277833B1 (ko) | 2013-02-20 | 2021-07-14 | 칼라 파마슈티컬스, 인크. | 치료 화합물 및 그의 용도 |
US9688688B2 (en) | 2013-02-20 | 2017-06-27 | Kala Pharmaceuticals, Inc. | Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof |
AU2014342042B2 (en) | 2013-11-01 | 2017-08-17 | KALA BIO, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
US9890173B2 (en) | 2013-11-01 | 2018-02-13 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
CA3036065A1 (fr) | 2016-09-08 | 2018-03-15 | Kala Pharmaceuticals, Inc. | Formes cristallines de composes therapeutiques et leurs utilisations |
EP3509422A4 (fr) | 2016-09-08 | 2020-05-20 | Kala Pharmaceuticals, Inc. | Formes cristallines de composés thérapeutiques et leurs utilisations |
EP3509423A4 (fr) | 2016-09-08 | 2020-05-13 | Kala Pharmaceuticals, Inc. | Formes cristallines de composés thérapeutiques et leurs utilisations |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU760027B2 (en) * | 1998-07-02 | 2003-05-08 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
-
2001
- 2001-10-19 CA CA002426684A patent/CA2426684A1/fr not_active Abandoned
- 2001-10-19 WO PCT/US2001/050527 patent/WO2002060868A2/fr not_active Application Discontinuation
- 2001-10-19 EP EP01998114A patent/EP1332134A2/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1332134A2 (fr) | 2003-08-06 |
WO2002060868A2 (fr) | 2002-08-08 |
WO2002060868A3 (fr) | 2003-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6358985B1 (en) | Inhibitors of prenyl-protein transferase | |
CA2424222A1 (fr) | Inhibiteurs de la prenyl-proteine transferase | |
US20020052380A1 (en) | Inhibitors of prenyl-protein transferase | |
US6441017B1 (en) | Inhibitors of prenyl-protein transferase | |
US6350755B1 (en) | Inhibitors of prenyl-protein transferase | |
AU760028B2 (en) | Inhibitors of prenyl-protein transferase | |
WO2001060368A1 (fr) | Inhibiteurs de la prenyle proteine transferase | |
US6329376B1 (en) | Inhibitors of prenyl-protein transferase | |
WO2001045707A1 (fr) | Inhibiteurs de prenyl-proteine transferase | |
US6632818B2 (en) | Inhibitors of prenyl-protein transferase | |
CA2426684A1 (fr) | Inhibiteurs de la prenyl-proteine transferase | |
US6525074B2 (en) | Inhibitors of prenyl-protein transferase | |
US6316436B1 (en) | Inhibitors of prenyl-protein transferase | |
US6566385B2 (en) | Inhibitors of prenyl-protein transferase | |
US6610722B2 (en) | Inhibitors of prenyl-protein transferase | |
AU762440B2 (en) | Inhibitors of prenyl-protein transferase | |
WO2002079147A2 (fr) | Inhibiteurs de la prenyl-proteine-transferase | |
US6413964B1 (en) | Inhibitors of prenyl-protein transferase | |
US20040110764A1 (en) | Inhibitors of prenyl-protein transferase | |
US20020022633A1 (en) | Inhibitors of prenyl-protein transferase | |
US6534506B2 (en) | Inhibitors of prenyl-protein transferase | |
US6380228B1 (en) | Inhibitors of prenyl-protein transferase | |
WO2002078702A1 (fr) | Inhibiteurs de la prenyl-proteine transferase | |
WO2002020015A1 (fr) | Inhibiteurs de prenyle-proteine transferase | |
WO2001045704A1 (fr) | Inhibiteurs de la prenyl-proteine transferase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |